Arteriovenous dialysis access-associated transvenous pacemaker infection

Roger Carrillo, J. D. Garisto, Loay Salman, A. Asif

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Pacemaker (PM), implantable cardioverter defibrillator and cardiac resynchronization therapy devices also provide support to chronic hemodialysis patients with cardiac rhythm abnormalities. However, these devices can get infected. In general, device infection is either primary ormetastatic spread from a distant source. Arteriovenous grafts are commonly used to provide dialysis therapy. Compared to a fistula an arteriovenous graft runs a higher risk of infection. In this analysis, we report 2 chronic hemodialysis patients who have been successfully receiving dialysis through an arteriovenous graft for approximately 2 years. Both had had a PMdevice for about the same duration. Access infection necessitated surgical removal of the arteriovenous graft in these patients. However, due to bacteremia (methicillin-resistant Staphylococcal aureus (MRSA)), infection spread to involve the transvenous PM leads in both patients. In 1 patient the infection also involved the PM pocket. Lead and wound culture confirmed MRSA in both patients. PM device and leads were removed in both patients. After the resolution of bacteremia, both patients received an epicardial pacemaker. None of the patients had valvular endocarditis. While dialysis was provided with a catheter, an arteriovenous fistula was planned. In conclusion, contamination of the transvenous PM device can occur due to hematogenous spread of infection from an infected arteriovenous graft. Epicardial instead of a transvenous PM might be the better option for such patients to provide long-term cardiac rhythm support.

Original languageEnglish
Pages (from-to)174-178
Number of pages5
JournalClinical Nephrology
Volume75
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Dialysis
Infection
Transplants
Equipment and Supplies
Methicillin Resistance
Arteriovenous Fistula
Bacteremia
Renal Dialysis
Cardiac Resynchronization Therapy Devices
Staphylococcal Infections
Implantable Defibrillators
Endocarditis
Catheters
Wounds and Injuries

Keywords

  • Arteriovenous dialysis access
  • Cardiac devices
  • Hemodialysis
  • Pacemaker
  • Transvenous pacemaker

ASJC Scopus subject areas

  • Nephrology

Cite this

Arteriovenous dialysis access-associated transvenous pacemaker infection. / Carrillo, Roger; Garisto, J. D.; Salman, Loay; Asif, A.

In: Clinical Nephrology, Vol. 75, No. 2, 01.02.2011, p. 174-178.

Research output: Contribution to journalArticle

Carrillo, R, Garisto, JD, Salman, L & Asif, A 2011, 'Arteriovenous dialysis access-associated transvenous pacemaker infection', Clinical Nephrology, vol. 75, no. 2, pp. 174-178. https://doi.org/10.5414/CN106479
Carrillo, Roger ; Garisto, J. D. ; Salman, Loay ; Asif, A. / Arteriovenous dialysis access-associated transvenous pacemaker infection. In: Clinical Nephrology. 2011 ; Vol. 75, No. 2. pp. 174-178.
@article{c0bc2d25c86a4d28850afb78cbbc80a0,
title = "Arteriovenous dialysis access-associated transvenous pacemaker infection",
abstract = "Pacemaker (PM), implantable cardioverter defibrillator and cardiac resynchronization therapy devices also provide support to chronic hemodialysis patients with cardiac rhythm abnormalities. However, these devices can get infected. In general, device infection is either primary ormetastatic spread from a distant source. Arteriovenous grafts are commonly used to provide dialysis therapy. Compared to a fistula an arteriovenous graft runs a higher risk of infection. In this analysis, we report 2 chronic hemodialysis patients who have been successfully receiving dialysis through an arteriovenous graft for approximately 2 years. Both had had a PMdevice for about the same duration. Access infection necessitated surgical removal of the arteriovenous graft in these patients. However, due to bacteremia (methicillin-resistant Staphylococcal aureus (MRSA)), infection spread to involve the transvenous PM leads in both patients. In 1 patient the infection also involved the PM pocket. Lead and wound culture confirmed MRSA in both patients. PM device and leads were removed in both patients. After the resolution of bacteremia, both patients received an epicardial pacemaker. None of the patients had valvular endocarditis. While dialysis was provided with a catheter, an arteriovenous fistula was planned. In conclusion, contamination of the transvenous PM device can occur due to hematogenous spread of infection from an infected arteriovenous graft. Epicardial instead of a transvenous PM might be the better option for such patients to provide long-term cardiac rhythm support.",
keywords = "Arteriovenous dialysis access, Cardiac devices, Hemodialysis, Pacemaker, Transvenous pacemaker",
author = "Roger Carrillo and Garisto, {J. D.} and Loay Salman and A. Asif",
year = "2011",
month = "2",
day = "1",
doi = "10.5414/CN106479",
language = "English",
volume = "75",
pages = "174--178",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "2",

}

TY - JOUR

T1 - Arteriovenous dialysis access-associated transvenous pacemaker infection

AU - Carrillo, Roger

AU - Garisto, J. D.

AU - Salman, Loay

AU - Asif, A.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Pacemaker (PM), implantable cardioverter defibrillator and cardiac resynchronization therapy devices also provide support to chronic hemodialysis patients with cardiac rhythm abnormalities. However, these devices can get infected. In general, device infection is either primary ormetastatic spread from a distant source. Arteriovenous grafts are commonly used to provide dialysis therapy. Compared to a fistula an arteriovenous graft runs a higher risk of infection. In this analysis, we report 2 chronic hemodialysis patients who have been successfully receiving dialysis through an arteriovenous graft for approximately 2 years. Both had had a PMdevice for about the same duration. Access infection necessitated surgical removal of the arteriovenous graft in these patients. However, due to bacteremia (methicillin-resistant Staphylococcal aureus (MRSA)), infection spread to involve the transvenous PM leads in both patients. In 1 patient the infection also involved the PM pocket. Lead and wound culture confirmed MRSA in both patients. PM device and leads were removed in both patients. After the resolution of bacteremia, both patients received an epicardial pacemaker. None of the patients had valvular endocarditis. While dialysis was provided with a catheter, an arteriovenous fistula was planned. In conclusion, contamination of the transvenous PM device can occur due to hematogenous spread of infection from an infected arteriovenous graft. Epicardial instead of a transvenous PM might be the better option for such patients to provide long-term cardiac rhythm support.

AB - Pacemaker (PM), implantable cardioverter defibrillator and cardiac resynchronization therapy devices also provide support to chronic hemodialysis patients with cardiac rhythm abnormalities. However, these devices can get infected. In general, device infection is either primary ormetastatic spread from a distant source. Arteriovenous grafts are commonly used to provide dialysis therapy. Compared to a fistula an arteriovenous graft runs a higher risk of infection. In this analysis, we report 2 chronic hemodialysis patients who have been successfully receiving dialysis through an arteriovenous graft for approximately 2 years. Both had had a PMdevice for about the same duration. Access infection necessitated surgical removal of the arteriovenous graft in these patients. However, due to bacteremia (methicillin-resistant Staphylococcal aureus (MRSA)), infection spread to involve the transvenous PM leads in both patients. In 1 patient the infection also involved the PM pocket. Lead and wound culture confirmed MRSA in both patients. PM device and leads were removed in both patients. After the resolution of bacteremia, both patients received an epicardial pacemaker. None of the patients had valvular endocarditis. While dialysis was provided with a catheter, an arteriovenous fistula was planned. In conclusion, contamination of the transvenous PM device can occur due to hematogenous spread of infection from an infected arteriovenous graft. Epicardial instead of a transvenous PM might be the better option for such patients to provide long-term cardiac rhythm support.

KW - Arteriovenous dialysis access

KW - Cardiac devices

KW - Hemodialysis

KW - Pacemaker

KW - Transvenous pacemaker

UR - http://www.scopus.com/inward/record.url?scp=79251470135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251470135&partnerID=8YFLogxK

U2 - 10.5414/CN106479

DO - 10.5414/CN106479

M3 - Article

C2 - 21255549

AN - SCOPUS:79251470135

VL - 75

SP - 174

EP - 178

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 2

ER -